Bellevue Group’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$337K	Sell	24,008 -11,692	-33%	-$164K	0.01%	113
2025 Q1	$558K	Sell	35,700 -3,800	-10%	-$59.4K	0.01%	115
2024 Q4	$550K	Hold	39,500	–	–	0.01%	124
2024 Q3	$367K	Buy	39,500 +22,000	+126%	+$205K	0.01%	135
2024 Q2	$163K	Buy	+17,500	New	+$163K	﹤0.01%	155